Importantly, Waniczek et al. [105] extended these findings to saliva, demonstrating markedly elevated salivary chemerin levels in CRC patients with 99% specificity and 100% sensitivity at a cut-off of 231.24 ng/mL, though the small sample size limited the analysis and requires independent validation. The gene discussed is RARRES2; the disease is colorectal carcinoma.